Kevin Hibbert
Analyst · expectations and about material factors or assumptions applied in making forward-looking statements, please consult the MD&A for the quarter and Sprott's other filings with the Canadian and U.S. securities regulators. I will now turn the conference over to Mr. Whitney George. Please go ahead, Mr. George
Thanks, Whitney, and good morning, everyone. I'll start on Slide 5, which provides the usual summary of our historical AUM. As Whitney alluded to earlier, AUM finished the quarter at $25.1 billion, down $235 million or 1% from March 31 of this year, but is actually up $1.7 billion or 7% since the end of last year. On a 3 months ended basis, our AUM was negatively impacted by market value depreciation across the majority of our fund products that was only partially offset by new capital raises and inflows to our private strategies and exchange listed products. However, on a 6 months ended basis, we did benefit from the full effects of this year's capital raise and inflows to our private strategies funds as well as good as the market activity levels in our exchange-listed products and a strong first quarter of market value appreciation across the majority of our funds. Slide 6 provides a brief look at our 3- and 6-month earnings. Adjusted base EBITDA was $18 million in the quarter, up slightly from the same 3-month period ended last year. The increase in the quarter was due to higher average AUM in our exchange-listed products and private strategies more than offsetting lower commission income in the quarter due to the sale of our former Canadian broker-dealer. Adjusted base EBITDA was $35.3 million on a year-to-date basis, down $808,000 or 2% from the same 6-month period ended last year. That decrease was due to lower commission income on the sale of the Canadian dealers as I mentioned earlier, as well as slower aftermarket activity in our Uranium Trust. The lower commission income on a year-to-date basis was nearly offset by growth in net fees on improved AUM and we expect net fee levels to increase even further in the second half of the year, leading to the eventual replacement of low-margin commission income from our broker-dealer with higher margin fees from our exchange products and Private strategy segments. So all told, we have grown annual adjusted base EBITDA consistently over the last 5 years, and we anticipate more of the same for 2023, although at a much lower trajectory than previous years given the challenging 2023 operating environment. Lastly, as you can see on Slide 7, as part of our ongoing treasury and balance sheet management program. During the quarter, we paid down $20 million or 37% of our outstanding debt facility. We expect the total debt outstanding down by another 13% or so in the second half of the year, such that our total outstanding debt coming out of 2022 will be lower -- sorry, 2023 will be lower than where it was coming out of 2022. Subsequent to quarter end, we completed a review of our current and near-term funding and borrowing needs, and determine that we no longer require a $120 million credit facility. Consequently, management decided to lower the maximum borrowing capacity under the credit facility by $45 million to $75 million, offsetting the reduction in borrowing capacity is the release of capital restrictions on the sale of our former Canadian broker-dealer that closed earlier this quarter as well as the eventual monetization of shares that we received on the realization of a previously unrecorded contingent asset from a historical acquisition. For more information on our revenues, expenses, EBITDA and balance sheet metrics, you can refer to the supplemental information section of this presentation as well as our second quarter MD&A that we filed earlier this morning. With that said, I'll pass things over to John.